Our experience in autoimmune diseases and therapies serves as a
strong foundation for continuing research in this area.
Exploring Unchartered Territories of Treatment
we continue to push innovation within our immunology pipeline –
considering multiple scientific approaches and investigating novel
solutions to help improve patient care across a variety of autoimmune
diseases with unmet needs.
active clinical trials in immunology
new molecular compounds in Phase I, II or III clinical trials in immunology
immune-mediated inflammatory conditions being investigated
countries with active clinical trials in Immunology
Our scientists are more determined than ever before to make a
difference in the lives of people living with immune mediated diseases.
Cookie technology helps us bring you the best possible experience
when you visit this website. Please let us know if you're happy to
accept cookies. To learn more about our policy on cookies, please
Leave the UK site
The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.
You are leaving to a site that is not controlled by AbbVie. The “accept” button below will take you out of AbbVie family of websites. Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience. The inclusion of any link does not imply endorsement of the linked site by AbbVie.
I understand and would like to continue to the site